54 results
Page 2 of 3
8-K
EX-99.1
4tdltl2sx2rfef3 zcr
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
u9gtnvlxry7 5gpzvj
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.1
r8eae6a
14 Feb 22
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
12:00am
8-K
EX-99.1
q3zi4
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
7ehu4w m2
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
r4ae3 79r
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
db60b y5fbclve2h2mdt
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
4ejgoz
1 Jul 21
Other Events
6:11am
8-K
EX-99.1
wm670io6am88oj
14 Jun 21
Other Events
5:21pm
8-K
EX-99.1
iear3
26 May 21
Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of Recently Announced Private Placement Financing
10:17am
8-K
EX-99.1
15y9qgk0yps4q3uv
21 May 21
Larimar Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for CTI-1601 in Friedreich’s Ataxia
7:28am
8-K
EX-99.1
hkr8jb6xh07 r9l
18 May 21
Other Events
3:09pm
8-K
EX-99.1
m31rn jmp5
11 May 21
Other Events
8:34am
8-K
EX-99.2
6cgsomyq0t
11 May 21
Other Events
8:34am
8-K
EX-99.1
urlm zm4wk4zd
10 May 21
Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results
4:15pm
8-K
EX-99.1
5xa 89bzf0g
4 Mar 21
Larimar Therapeutics Reports Fourth Quarter and Full Year 2020 Operating and Financial Results
7:30am